Skip to content

Braveheart Bio

US · BRVE #2845 by market cap Listed 2026
20.39 +1.12 +5.81%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

Momentum strategy signal
Hold
Analyst consensus
Buy

Signals diverge - worth digging into why.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 5 analysts

Buy
Avg price target 45.50 +123.1%
Price target rangecurrent 20.39
Low40.00
Avg45.50
High49.00
Buy 100% Hold 0% Sell 0%
Recent ratings (13)
DateFirmAnalystRatingTarget
2026-11-11 Goldman Sachs -- Buy 49.00
2026-11-09 Stifel -- Buy 45.00
2026-11-07 Cantor Fitzgerald -- Buy 40.00
2026-10-19 Cantor Fitzgerald -- Buy 40.00
2026-10-01 Stifel -- Buy 45.00
2026-09-09 Stifel -- Buy 45.00
2026-09-08 Goldman Sachs -- Buy 48.00
2026-09-06 Stifel -- Buy 45.00
2026-08-31 TD Cowen -- Buy --
2026-08-31 Cantor Fitzgerald -- Buy 40.00
2026-08-31 Jefferies -- Buy 48.00
2026-08-31 Stifel -- Buy 45.00
2026-08-31 Goldman Sachs -- Buy 48.00

Price target trend monthly average, last 3 years

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Braveheart Bio discussion 0 comments

Add a comment